FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311803722> ?p ?o ?g. }

• W4311803722 abstract "Abstract Background Despite causing increased morbidity and mortality, pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD) patients (COPD-PH) lacks treatment, due to incomplete understanding of its pathogenesis. Hypertrophy of pulmonary arterial walls and pruning of the microvasculature with loss of capillary beds are known features of pulmonary vascular remodeling in COPD. The remodeling features of pulmonary medium- and smaller vessels in COPD-PH lungs are less well described and may be linked to maladaptation of endothelial cells to chronic cigarette smoking (CS). MicroRNA-126 (miR126), a master regulator of endothelial cell fate, has divergent functions that are vessel-size specific, supporting the survival of large vessel endothelial cells and inhibiting the proliferation of microvascular endothelial cells. Since CS decreases miR126 in microvascular lung endothelial cells, we set out to characterize the remodeling by pulmonary vascular size in COPD-PH and its relationship with miR126 in COPD and COPD-PH lungs. Methods Deidentified lung tissue was obtained from individuals with COPD with and without PH and from non-diseased non-smokers and smokers. Pulmonary artery remodeling was assessed by ⍺-smooth muscle actin (SMA) abundance via immunohistochemistry and analyzed by pulmonary artery size. miR126 and miR126-target abundance were quantified by qPCR. The expression levels of ceramide, ADAM9, and endothelial cell marker CD31 were assessed by immunofluorescence. Results Pulmonary arteries from COPD and COPD-PH lungs had significantly increased SMA abundance compared to non-COPD lungs, especially in small pulmonary arteries and the lung microvasculature. This was accompanied by significantly fewer endothelial cell markers and increased pro-apoptotic ceramide abundance. miR126 expression was significantly decreased in lungs of COPD individuals. Of the targets tested ( SPRED1, VEGF, LAT1, ADAM9 ), lung miR126 most significantly inversely correlated with ADAM9 expression. Compared to controls, ADAM9 was significantly increased in COPD and COPD-PH lungs, predominantly in small pulmonary arteries and lung microvasculature. Conclusion Both COPD and COPD-PH lungs exhibited significant remodeling of the pulmonary vascular bed of small and microvascular size, suggesting these changes may occur before or independent of the clinical development of PH. Decreased miR126 expression with reciprocal increase in ADAM9 may regulate endothelial cell survival and vascular remodeling in small pulmonary arteries and lung microvasculature in COPD and COPD-PH." @default.
• W4311803722 created "2022-12-28" @default.
• W4311803722 creator A5011296651 @default.
• W4311803722 creator A5016660645 @default.
• W4311803722 creator A5017129942 @default.
• W4311803722 creator A5017993625 @default.
• W4311803722 creator A5026411789 @default.
• W4311803722 creator A5041011399 @default.
• W4311803722 creator A5049292667 @default.
• W4311803722 creator A5049513894 @default.
• W4311803722 creator A5053367377 @default.
• W4311803722 creator A5058022497 @default.
• W4311803722 creator A5067790267 @default.
• W4311803722 creator A5090398738 @default.
• W4311803722 date "2022-12-15" @default.
• W4311803722 modified "2023-10-11" @default.
• W4311803722 title "Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension" @default.
• W4311803722 cites W10297047 @default.
• W4311803722 cites W1502095639 @default.
• W4311803722 cites W180821421 @default.
• W4311803722 cites W1969490421 @default.
• W4311803722 cites W1970911936 @default.
• W4311803722 cites W1973117104 @default.
• W4311803722 cites W2013211910 @default.
• W4311803722 cites W2038161096 @default.
• W4311803722 cites W2050560100 @default.
• W4311803722 cites W2074936272 @default.
• W4311803722 cites W2079648278 @default.
• W4311803722 cites W2084835859 @default.
• W4311803722 cites W2088062477 @default.
• W4311803722 cites W2107277218 @default.
• W4311803722 cites W2110973939 @default.
• W4311803722 cites W2113236035 @default.
• W4311803722 cites W2125619852 @default.
• W4311803722 cites W2127131462 @default.
• W4311803722 cites W2129994868 @default.
• W4311803722 cites W2137661533 @default.
• W4311803722 cites W2138563089 @default.
• W4311803722 cites W2144845371 @default.
• W4311803722 cites W2165672248 @default.
• W4311803722 cites W2192080449 @default.
• W4311803722 cites W2515192623 @default.
• W4311803722 cites W2740775631 @default.
• W4311803722 cites W2766562064 @default.
• W4311803722 cites W2778338359 @default.
• W4311803722 cites W2805718585 @default.
• W4311803722 cites W2913106892 @default.
• W4311803722 cites W2921556019 @default.
• W4311803722 cites W2950240952 @default.
• W4311803722 cites W2997170638 @default.
• W4311803722 cites W3004328528 @default.
• W4311803722 cites W3013169746 @default.
• W4311803722 cites W3093977070 @default.
• W4311803722 cites W3103711573 @default.
• W4311803722 cites W3112462656 @default.
• W4311803722 cites W3160395963 @default.
• W4311803722 cites W4211102601 @default.
• W4311803722 doi "https://doi.org/10.1186/s12931-022-02267-4" @default.
• W4311803722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36522710" @default.
• W4311803722 hasPublicationYear "2022" @default.
• W4311803722 type Work @default.
• W4311803722 citedByCount "2" @default.
• W4311803722 countsByYear W43118037222023 @default.
• W4311803722 crossrefType "journal-article" @default.
• W4311803722 hasAuthorship W4311803722A5011296651 @default.
• W4311803722 hasAuthorship W4311803722A5016660645 @default.
• W4311803722 hasAuthorship W4311803722A5017129942 @default.
• W4311803722 hasAuthorship W4311803722A5017993625 @default.
• W4311803722 hasAuthorship W4311803722A5026411789 @default.
• W4311803722 hasAuthorship W4311803722A5041011399 @default.
• W4311803722 hasAuthorship W4311803722A5049292667 @default.
• W4311803722 hasAuthorship W4311803722A5049513894 @default.
• W4311803722 hasAuthorship W4311803722A5053367377 @default.
• W4311803722 hasAuthorship W4311803722A5058022497 @default.
• W4311803722 hasAuthorship W4311803722A5067790267 @default.
• W4311803722 hasAuthorship W4311803722A5090398738 @default.
• W4311803722 hasBestOaLocation W43118037221 @default.
• W4311803722 hasConcept C126322002 @default.
• W4311803722 hasConcept C142724271 @default.
• W4311803722 hasConcept C164705383 @default.
• W4311803722 hasConcept C2776780178 @default.
• W4311803722 hasConcept C2777714996 @default.
• W4311803722 hasConcept C2778939058 @default.
• W4311803722 hasConcept C2780394083 @default.
• W4311803722 hasConcept C2780930700 @default.
• W4311803722 hasConcept C2780940725 @default.
• W4311803722 hasConcept C71924100 @default.
• W4311803722 hasConcept C99322962 @default.
• W4311803722 hasConceptScore W4311803722C126322002 @default.
• W4311803722 hasConceptScore W4311803722C142724271 @default.
• W4311803722 hasConceptScore W4311803722C164705383 @default.
• W4311803722 hasConceptScore W4311803722C2776780178 @default.
• W4311803722 hasConceptScore W4311803722C2777714996 @default.
• W4311803722 hasConceptScore W4311803722C2778939058 @default.
• W4311803722 hasConceptScore W4311803722C2780394083 @default.
• W4311803722 hasConceptScore W4311803722C2780930700 @default.
• W4311803722 hasConceptScore W4311803722C2780940725 @default.
• W4311803722 hasConceptScore W4311803722C71924100 @default.
• W4311803722 hasConceptScore W4311803722C99322962 @default.
• W4311803722 hasFunder F4320337338 @default.

• next